Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lymphoma"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 3797
Tytuł:
Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
Autorzy:
Khurana S; From the Division of Hematology/Oncology, University of Arizona Cancer Center, Tucson (Khurana).
Heckman MG; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Craig FE; the Divisions of Hematopathology (Craig) and Hematology and Medical Oncology (Sproat), Mayo Clinic Arizona, Phoenix.
Cochuyt JJ; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Greipp P; the Divisions of Laboratory Genetics (Greipp) and Hematology (Litzow), Mayo Clinic, Rochester, Minnesota.
Rahman ZA; the Division of Hematology and Medical Oncology, Sanford Roger Maris Cancer Center, Fargo, North Dakota (Rahman).
Sproat LZ; the Divisions of Hematopathology (Craig) and Hematology and Medical Oncology (Sproat), Mayo Clinic Arizona, Phoenix.
Litzow M; the Divisions of Laboratory Genetics (Greipp) and Hematology (Litzow), Mayo Clinic, Rochester, Minnesota.
Foran JM; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Jiang LJ; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Apr 01; Vol. 148 (4), pp. 471-475.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Lymphoma*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Lymphoma, B-Cell*
Adult ; Humans ; CD47 Antigen ; Receptors, CCR4 ; Interleukin-3 Receptor alpha Subunit ; T-Lymphocytes/pathology ; Proto-Oncogene Proteins c-bcl-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
Autorzy:
Li D; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Yuan Y; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Meng C; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Lin Z; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Zhao M; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Shi L; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China.
Li M; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Ye D; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Cai Y; Department of Clinical Medicine, Wenzhou Medical University, Chashan District, Wenzhou, Zhejiang Province, China.
He X; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China.
Ye H; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China.
Zhou S; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China.
Zhou H; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. .; Department of Hematology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. .
Gao S; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China. .; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2024 Mar 26; Vol. 16 (1), pp. 48. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents*/pharmacology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Adult ; Animals ; Humans ; Mice ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; DNA Methylation/genetics ; Lymphocytes/metabolism ; Mice, Knockout ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Sulfonamides/therapeutic use ; Homeodomain Proteins/genetics ; Homeodomain Proteins/metabolism ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia.
Autorzy:
Bwanika HC; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Leo IR; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Struyf N; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Talanti A; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Aswad L; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Konnur A; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Björklund AC; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Huddinge, Sweden.
Heyman M; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Rassidakis G; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Erkers T; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Seashore-Ludlow B; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Jafari R; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Pokrovskaja Tamm K; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 18; Vol. 14 (1), pp. 4000. Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Child ; Humans ; Autophagy ; Cell Line ; Glucocorticoids/therapeutic use ; Cell Line, Tumor ; Apoptosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neuropsychological task outcomes among survivors of childhood acute lymphoblastic leukemia in Malaysia.
Autorzy:
Alias H; Department of Pediatrics, Faculty of Medicine, The National University of Malaysia, 56000, Cheras, Kuala Lumpur, Malaysia. .
Mohd Ranai N; Department of Pediatrics, Faculty of Medicine, Universiti Teknologi Mara (UiTM), 47000, Shah Alam, Selangor, Malaysia.
Lau SCD; Department of Pediatrics, Faculty of Medicine, The National University of Malaysia, 56000, Cheras, Kuala Lumpur, Malaysia.
de Sonneville LMJ; Clinical Neurodevelopmental Sciences, Faculty of Social Sciences, Leiden University, Wassenaarseweg 52, 2333 AK, Leiden, The Netherlands.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 04; Vol. 14 (1), pp. 7915. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Executive Function*/physiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Humans ; Child, Preschool ; Child ; Malaysia/epidemiology ; Case-Control Studies ; Neuropsychological Tests ; Survivors/psychology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
Autorzy:
Kulczycka M; Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Derlatka K; Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Tasior J; Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Sygacz M; Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Lejman M; Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland.
Zawitkowska J; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 27; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Infant ; Humans ; Child ; Adolescent ; Molecular Targeted Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fatigue in children who have recently completed treatment for acute lymphoblastic leukemia: a longitudinal study.
Autorzy:
Walsh S; Institute for Social Neuroscience, ISN Psychology, Heidelberg, VIC, Australia.; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Mulraney M; Institute for Social Neuroscience, ISN Psychology, Heidelberg, VIC, Australia.; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
McCarthy MC; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.; Children's Cancer Centre, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia.
De Luca CR; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia. .; Children's Cancer Centre, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia. .
Pokaż więcej
Źródło:
Health and quality of life outcomes [Health Qual Life Outcomes] 2024 Mar 22; Vol. 22 (1), pp. 27. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:
Journal Article
MeSH Terms:
Quality of Life*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/psychology
Child ; Humans ; Longitudinal Studies ; Fatigue/psychology ; Self Report
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Disseminated Nocardia nova in a child with relapsed acute lymphoblastic leukemia: a case report.
Autorzy:
Arahirwa V; University of North Carolina School of Medicine, Chapel Hill, USA. victor_.
Thahir S; University of North Carolina School of Medicine, Chapel Hill, USA.
Hernandez L; University of North Carolina School of Medicine, Chapel Hill, USA.
Willis ZI; University of North Carolina School of Medicine, Chapel Hill, USA.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 01; Vol. 24 (1), pp. 154. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Nocardia*
Nocardia Infections*/diagnosis
Nocardia Infections*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Male ; Child ; Humans ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; Anti-Bacterial Agents/therapeutic use
SCR Organism:
Nocardia nova
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
Autorzy:
Hou Z; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China. houzhijie_.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China. houzhijie_.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China. houzhijie_.; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China. houzhijie_.
Ren Y; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China.
Zhang X; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Huang D; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China.
Yan F; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China.
Sun W; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Zhang W; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Zhang Q; Department of Pathology, Dalian Medical University, Dalian, 116044, China.
Fu X; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Lang Z; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Chu C; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Zou B; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Gao B; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China.
Jin B; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Kang Z; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .
Liu Q; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China. .
Yan J; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Apr 02; Vol. 22 (1), pp. 211. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Trans-Activators*/metabolism
Animals ; Humans ; Mice ; Doxorubicin ; E1A-Associated p300 Protein ; Interleukin-3 ; Interleukin-3 Receptor alpha Subunit
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
Autorzy:
Mohanty SK; Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Diwaker P; Department of Pathology, University College of Medical Sciences, Delhi, India.
Mishra SK; Department of Medical Oncology, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.
Jha S; Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.
Lobo A; Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.
Panda SP; Department of Pediatric Oncology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
Sharma S; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Kumar M; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Arora S; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Mallik V; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Jain D; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Jain E; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Chakrabarti I; Department of Pathology, AIIMS, Kalyani, West Bengal, India.
Varshney J; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Beg A; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Dixit M; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Baisakh MR; Department of Pathology, Prolife Diagnostics, Bhubaneswar, Odisha, India.
Naik S; Department of Pathology, Prolife Diagnostics, Bhubaneswar, Odisha, India.
Sahoo SK; Department of Pediatric Surgery, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
Akgul M; Department of Pathology, Albany Medical Center, Albany, NY, USA.
Balzer BL; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Amin MB; Department of Pathology and Laboratory, University of Southern California Keck School, Los Angeles, CA, USA.
Parwani AV; Department of Pathology and Laboratory, Wexner Medical Center, Pathology, Columbus, OH, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2024 Apr; Vol. 32 (2), pp. 294-303. Date of Electronic Publication: 2023 Jun 13.
Typ publikacji:
Journal Article
MeSH Terms:
Medulloblastoma*
Sarcoma, Synovial*/diagnosis
Sarcoma, Synovial*/genetics
Rhabdomyosarcoma, Embryonal*
Neuroblastoma*/diagnosis
Wilms Tumor*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Cerebellar Neoplasms*
Kidney Neoplasms*/diagnosis
Kidney Neoplasms*/genetics
Humans ; Child ; Biomarkers, Tumor ; Diagnosis, Differential ; GATA3 Transcription Factor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Different Levels of Therapeutic Strategies to Recover the Microbiome to Prevent/Delay Acute Lymphoblastic Leukemia (ALL) or Arrest Its Progression in Children.
Autorzy:
Aronica TS; Complex Operative Unit of Clinical Pathology, ARNAS Civico Di Cristina e Benfratelli Hospitals, 90127 Palermo, Italy.
Carella M; Complex Operative Unit of Clinical Pathology, ARNAS Civico Di Cristina e Benfratelli Hospitals, 90127 Palermo, Italy.
Balistreri CR; Cellular, Molecular and Clinical Pathological Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90134 Palermo, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 31; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 31.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Microbiota*
Gastrointestinal Microbiome*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Hematologic Neoplasms*
Infant, Newborn ; Humans ; Child ; Fetus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling.
Autorzy:
Mosquera Orgueira A; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain. .; Health Research Institute of Santiago de Compostela, Compostela, Spain. .
Krali O; Department of Medical Sciences, Molecular Precision Medicine, Uppsala University, Uppsala, Sweden.; Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Pérez Míguez C; Health Research Institute of Santiago de Compostela, Compostela, Spain.
Peleteiro Raíndo A; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain.; Health Research Institute of Santiago de Compostela, Compostela, Spain.
Díaz Arias JÁ; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain.; Health Research Institute of Santiago de Compostela, Compostela, Spain.
González Pérez MS; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain.; Health Research Institute of Santiago de Compostela, Compostela, Spain.
Pérez Encinas MM; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain.; Health Research Institute of Santiago de Compostela, Compostela, Spain.
Fernández Sanmartín M; Health Research Institute of Santiago de Compostela, Compostela, Spain.; Department of Pediatric Medicine, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Sinnet D; Research Center, CHU Sainte-Justine, Montréal, Canada.; Department of Pediatrics, Université de Montréal, Montreal, Canada.
Heyman M; Childhood Cancer Research Unit, Karolinska Institutet, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.; For the Nordic Society of Pediatric Hematology and Oncology (NOPHO), Stockholm, Sweden.
Lönnerholm G; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.; For the Nordic Society of Pediatric Hematology and Oncology (NOPHO), Stockholm, Sweden.
Norén-Nyström U; Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.; For the Nordic Society of Pediatric Hematology and Oncology (NOPHO), Stockholm, Sweden.
Schmiegelow K; Pediatrics and Adolescent Medicine, Rigshospitalet, and the Medical Faculty, Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; For the Nordic Society of Pediatric Hematology and Oncology (NOPHO), Stockholm, Sweden.
Nordlund J; Department of Medical Sciences, Molecular Precision Medicine, Uppsala University, Uppsala, Sweden.; Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2024 Mar 28; Vol. 16 (1), pp. 49. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Child ; Humans ; Canada ; Treatment Outcome ; Prognosis ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia.
Autorzy:
Yang N; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China.; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Zhang C; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China.
Zhang Y; Department of Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Fan Y; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China.; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Zhang J; Department of Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Lin X; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China.; Department of Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Guo T; Department of Gynecology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Gu Y; State Key Laboratory of Biotherapy and Cancer Center, Sichuan University, Chengdu, China.
Wu J; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Gao J; School of Pharmacy, Zunyi Medical University, Zunyi, China.
Zhao X; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China. .; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China. .; Department of Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China. .
He Z; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China. .; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China. .; Key Laboratory of Adult Stem Cell Translational Research, Chinese Academy of Medical Sciences), Guiyang, China. .; Department of Pediatrics, the Affiliated Hospital of Zunyi Medical University, Zunyi, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Mar 13; Vol. 22 (1), pp. 274. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, Chimeric Antigen*/metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Mice ; Animals ; Antigens, CD19/genetics ; Antigens, CD19/metabolism ; Cytotoxicity, Immunologic/genetics ; Cell Line, Tumor ; Killer Cells, Natural ; Immunotherapy, Adoptive ; RNA, Messenger/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Changes in the Concentrations of Proangiogenic Cytokines in Human Brain Glioma and Acute Lymphoblastic Leukemia.
Autorzy:
Oldak L; Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.
Zielinska Z; Doctoral School of Exact and Natural Science, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.
Milewska P; Biobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
Chludzinska-Kasperuk S; Biobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
Latoch E; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Konończuk K; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Krawczuk-Rybak M; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Starosz A; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
Grubczak K; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
Reszeć J; Biobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.; Department of Medical Pathology, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
Gorodkiewicz E; Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Glioma*/metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Male ; Adult ; Child ; Humans ; Vascular Endothelial Growth Factor A/metabolism ; Cytokines/metabolism ; Fibroblast Growth Factor 2/metabolism ; Vascular Endothelial Growth Factors/metabolism ; Brain/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic Leukemia.
Autorzy:
Cruz-Miranda GM; Programa de Doctorado, Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.; Laboratorio de Innovación en Medicina de Precisión Núcleo A, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
Olarte-Carrillo I; Laboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México Dr. Eduardo Liceaga, Mexico City 06720, Mexico.
Bárcenas-López DA; Programa de Doctorado, Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.; Laboratorio de Innovación en Medicina de Precisión Núcleo A, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
Martínez-Tovar A; Laboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México Dr. Eduardo Liceaga, Mexico City 06720, Mexico.
Ramírez-Bello J; Subdirección de Investigación Clínica, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
Ramos-Peñafiel CO; Departamento de Hematología, Hospital General de México Dr. Eduardo Liceaga, Mexico City 06720, Mexico.
García-Laguna AI; Laboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México Dr. Eduardo Liceaga, Mexico City 06720, Mexico.
Cerón-Maldonado R; Programa de Doctorado, Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.; Laboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México Dr. Eduardo Liceaga, Mexico City 06720, Mexico.
May-Hau D; Laboratorio de Innovación en Medicina de Precisión Núcleo A, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
Jiménez-Morales S; Laboratorio de Innovación en Medicina de Precisión Núcleo A, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 01; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Profiling*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Humans ; Transcriptome ; Biomarkers ; Recurrence ; Computational Biology ; SOXC Transcription Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL.
Autorzy:
Gutierrez-Camino A; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Caron M; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.; Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada.
Richer C; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Fuchs C; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Illarregi U; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
Poncelet L; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
St-Onge P; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Bataille AR; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Tremblay-Dauphinais P; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Lopez-Lopez E; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Pediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.
Camos M; Hematology Laboratory, Sant Joan de Déu Research Institute, Esplugues de Llobregat, 08950 Barcelona, Spain.
Ramirez-Orellana M; Department of Pediatric Hematology and Oncology, Niño Jesús University Hospital, 28009 Madrid, Spain.
Astigarraga I; Pediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; Department of Pediatrics, Cruces University Hospital, 48903 Barakaldo, Spain.
Lécuyer É; Institut de Recherches Cliniques de Montréal (IRCM), Montreal, QC H2W 1R7, Canada.; Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC H3C 3J7, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC H3A 0G4, Canada.
Bourque G; Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada.
Martin-Guerrero I; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Pediatric Oncology Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.
Sinnett D; Division of Hematology-Oncology, CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.; Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, QC H3C 3J7, Canada.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 25; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
RNA, Circular*/genetics
Humans ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An Anti-CD7 Antibody-Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leukemia (T-ALL).
Autorzy:
Wang S; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
Zhang R; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
Zhong K; Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Guo W; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
Tong A; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Jan 15; Vol. 14 (1). Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Journal Article
MeSH Terms:
Burkitt Lymphoma*
Immunoconjugates*/pharmacology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Adult ; Animals ; Child ; Humans ; Mice ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Antigens, CD7/immunology ; Antigens, CD7/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Plasma-derived exosomal miR-326, a prognostic biomarker and novel candidate for treatment of drug resistant pediatric acute lymphoblastic leukemia.
Autorzy:
Saffari N; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Hezar jarib Street, Isfahan, 81746-73441, Iran.
Rahgozar S; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Hezar jarib Street, Isfahan, 81746-73441, Iran. .
Faraji E; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Hezar jarib Street, Isfahan, 81746-73441, Iran.
Sahin F; Department of Genetics and Bioengineering, Yeditepe University, Atasehir, 34755, Istanbul, Turkey.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 06; Vol. 14 (1), pp. 691. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
MicroRNAs*/genetics
Humans ; Child ; Prognosis ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Systemic xanthogranuloma involving bone marrow and skin in a case of B-Lymphoblastic Leukemia.
Autorzy:
Mundada MC; Department of Laboratory Medicine, Basavatarakam Indo American Cancer Hospital, Banjara Hills, Hyderabad, Telangana, India.
Ahmed F; Department of Laboratory Medicine, Basavatarakam Indo American Cancer Hospital, Banjara Hills, Hyderabad, Telangana, India.
Kodandapani S; Department of Laboratory Medicine, Basavatarakam Indo American Cancer Hospital, Banjara Hills, Hyderabad, Telangana, India.
Patil V; Department of Medical Oncology, Basavatarakam Indo American Cancer Hospital, Banjara Hills, Hyderabad, Telangana, India.
Pokaż więcej
Źródło:
Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2024 Jan-Mar; Vol. 67 (1), pp. 185-188.
Typ publikacji:
Case Reports
MeSH Terms:
Xanthogranuloma, Juvenile*/diagnosis
Xanthogranuloma, Juvenile*/pathology
Xanthomatosis*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Infant ; Child ; Humans ; Child, Preschool ; Bone Marrow/pathology ; Skin/pathology ; Histiocytes/pathology
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma.
Autorzy:
Bansal D; Department of Pathology, Molecular Diagnostics and Transfusion Services, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India Department of Laboratory Services, Molecular Diagnostics and Transfusion Services, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.
Pasricha S
Gupta G
Sharma A
Durga G
Kamboj M
Mehta A
Pokaż więcej
Źródło:
Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2024 Jan-Mar; Vol. 67 (1), pp. 141-144.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Thymoma*/diagnosis
Thymoma*/pathology
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Thymus Neoplasms*/diagnosis
Thymus Neoplasms*/pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Lymphoma, T-Cell*
Humans ; Immunohistochemistry ; Proto-Oncogene Proteins ; Adaptor Proteins, Signal Transducing ; LIM Domain Proteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Thiophene derivative inflicts cytotoxicity via an intrinsic apoptotic pathway on human acute lymphoblastic leukemia cells.
Autorzy:
Swain RM; Department of Biological Sciences, The Border Biomedical Research Center, The University of Texas at El Paso, El Paso, Texas, United States of America.; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Paul Foster School of Medicine, Texas Tech University Health Science Center El Paso, El Paso, Texas, United States of America.
Sanchez A; Department of Biological Sciences, The Border Biomedical Research Center, The University of Texas at El Paso, El Paso, Texas, United States of America.
Gutierrez DA; Department of Biological Sciences, The Border Biomedical Research Center, The University of Texas at El Paso, El Paso, Texas, United States of America.
Varela-Ramirez A; Department of Biological Sciences, The Border Biomedical Research Center, The University of Texas at El Paso, El Paso, Texas, United States of America.
Aguilera RJ; Department of Biological Sciences, The Border Biomedical Research Center, The University of Texas at El Paso, El Paso, Texas, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 21; Vol. 18 (12), pp. e0295441. Date of Electronic Publication: 2023 Dec 21 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/pharmacology
Lymphoma*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Humans ; Cell Line, Tumor ; Thiophenes/pharmacology ; Cell Proliferation ; Apoptosis ; Drug Screening Assays, Antitumor ; Structure-Activity Relationship ; Molecular Structure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 3797

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies